Ian is an antitrust and competition lawyer based in London. He focuses in advising on all aspects of competition law with a particular focus on competition and cartel investigations and merger control.
Ian has been involved in numerous significant cases in recent years, including acting for Asda in the UK Tobacco investigation and successful appeal; acting for PwC in the UK Audit market investigation; securing EU and other global merger control clearances in Delta/Virgin Atlantic and the $13.6 billion Thermo Fisher/Life Technologies transaction; and representing Stena in securing unconditional clearance before the Competition Commission in Stena/DFDS. Ian has also acted for parties in cartel investigations in the air passenger, air freight; groceries and freight forwarding sectors before UK, EU and other global regulators.
Ian was Assistant Director of Competition Policy at the UK Office of Fair Trading (OFT) in 2008-9, which gives him particular insights as to the regulatory approach and perspective.
Ian is a frequent speaker and author on competition issues, has been an Editor of Butterworth’s Competition Law and is an active member of the UK International Chamber of Commerce Competition Group. Ian is also a regular media commentator, including with the BBC, CNBC, the Wall Street Journal, the Financial Times, and the Guardian.
There are over 140 jurisdictions around the world now applying merger control (antitrust/competition) rules to transactions. .
October 19, 2017
There are over 140 jurisdictions around the world now applying merger control (antitrust/competition) rules to transactions, as well as an increasing number of foreign investment regimes..
October 19, 2017
On 7 June 2018, the Competition Appeal Tribunal (CAT) set aside in part the 2016 decision of the Competition and Markets Authority (CMA) that Pfizer and Flynn Pharma had abused their dominant positions by setting excessive and unfair prices for the capsule form of the epilepsy drug phenytoin sodium..
June 22, 2018
Companies enter joint ventures in a broad range of circumstances, for example: to share risks, to pool expertise, to increase market presence, reduce costs and realise efficiencies. Such arrangements offer many benefits. Competition authorities on the other hand are sceptical about companies cooperating, and there are notable cases of joint ventures having been investigated and sanctioned for anticompetitive behaviour..
May 02, 2018
Global law firm Norton Rose Fulbright has advised the Wu family, founders of Nature’s Care, on one of the largest private equity investments so far in 2018 to a Chinese consortium..
April 16, 2018
Global law firm Norton Rose Fulbright has been appointed as one of two firms to the global panel of DNV GL (the merged Det Norske Veritas and Germanisher Llloyd)..
August 09, 2017